Location History:
- San Francisco, CA (US) (2021 - 2023)
- Brisbane, CA (US) (2024)
Company Filing History:
Years Active: 2021-2025
Title: Ayman Naseri: Innovator in Intraocular Lens Technology
Introduction
Ayman Naseri is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of ophthalmology, particularly in the development of devices for intraocular lens implantation. With a total of 5 patents to his name, Naseri's work is paving the way for advancements in eye care.
Latest Patents
Naseri's latest patents include innovative devices designed to enhance the implantation of intraocular lens support devices. One of his notable inventions is an insertion tool that facilitates the delivery of an implantable lens support device into the eye. This tool features a proximal end region, a distal end region with a hook, and an intermediate region that is substantially planar. The design allows for insertion through a clear corneal incision, making the procedure less invasive.
Another significant patent involves a device that supports and positions an artificial intraocular lens within the eye. This implantable device includes a posterior platform with an anterior-facing surface and a central aperture. When implanted, it allows light to pass through the intraocular lens and the aperture towards the retina. The device is designed to be deployed posterior to the iris, ensuring that it does not contact the sclera after implantation.
Career Highlights
Ayman Naseri is currently associated with Long Bridge Medical, Inc., where he continues to innovate in the field of medical devices. His work focuses on improving surgical techniques and outcomes for patients undergoing eye surgeries.
Collaborations
Naseri collaborates with talented professionals in his field, including Matthew Clarke and Frank Brodie. Their combined expertise contributes to the development of cutting-edge technologies in ophthalmology.
Conclusion
Ayman Naseri's contributions to intraocular lens technology demonstrate his commitment to advancing medical science. His innovative patents and collaborations are set to improve the quality of care for patients with vision impairments.